VMX-C001 stops bleeding

Immediately restoring blood clotting in the presence of direct factor Xa anticoagulants

Read more

Latest news

VarmX raises € 12.5 million to develop VMX-C001

Funding enables clinical stage trials of lead compound VMX-C001.

Meet us

Bio€quity Europe

International Society on Thrombosis and Haemostasis, Melbourne, Australia